We hosted a live LinkedIn conversation with Amir Lotfi, Senior Director of Pre-Clinical at Beckley Psytech, to discuss how cutting-edge translational models are shaping the next generation of psychedelic therapeutics — including the company’s lead candidate, BPL-003.